CN1884528A - 与利培酮临床疗效相关的核酸序列 - Google Patents
与利培酮临床疗效相关的核酸序列 Download PDFInfo
- Publication number
- CN1884528A CN1884528A CN 200610028329 CN200610028329A CN1884528A CN 1884528 A CN1884528 A CN 1884528A CN 200610028329 CN200610028329 CN 200610028329 CN 200610028329 A CN200610028329 A CN 200610028329A CN 1884528 A CN1884528 A CN 1884528A
- Authority
- CN
- China
- Prior art keywords
- risperidone
- curative effect
- seq
- clinical curative
- clinical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960001534 risperidone Drugs 0.000 title claims abstract description 44
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 230000000694 effects Effects 0.000 title claims abstract description 26
- 150000007523 nucleic acids Chemical group 0.000 title abstract description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 title abstract 2
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 6
- 230000000295 complement effect Effects 0.000 claims abstract description 5
- 239000002773 nucleotide Substances 0.000 claims description 15
- 125000003729 nucleotide group Chemical group 0.000 claims description 15
- 102100020756 D(2) dopamine receptor Human genes 0.000 claims description 8
- 101000931901 Homo sapiens D(2) dopamine receptor Proteins 0.000 claims description 8
- 108020004414 DNA Proteins 0.000 abstract description 13
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 101150049660 DRD2 gene Proteins 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 5
- 102000053602 DNA Human genes 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000164 antipsychotic agent Substances 0.000 description 5
- 229940005529 antipsychotics Drugs 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011337 individualized treatment Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108091005479 5-HT2 receptors Proteins 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- MPUPANILEFVXCD-UHFFFAOYSA-N C1=CC=C2C(=C1)C=NO2.C1=CON=C1 Chemical class C1=CC=C2C(=C1)C=NO2.C1=CON=C1 MPUPANILEFVXCD-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000027776 Extrapyramidal disease Diseases 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960004170 clozapine Drugs 0.000 description 1
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 229940054010 other antipsychotics in atc Drugs 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
分组 | 样本数 | 基因型(频率%) | 等位位点数(频率%) |
无效组有效组POR(95%CI) | 5372 | AA AG GG27(50.94) 20(37.74) 6(11.32)52(72.22) 17(23.61) 3(4.17)0.040 | A G74(69.81) 32(30.19)121(84.03) 23(15.97)0.0070.440(0.239-0.808) |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100283294A CN100491528C (zh) | 2006-06-29 | 2006-06-29 | 与利培酮临床疗效相关的核酸序列 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100283294A CN100491528C (zh) | 2006-06-29 | 2006-06-29 | 与利培酮临床疗效相关的核酸序列 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1884528A true CN1884528A (zh) | 2006-12-27 |
CN100491528C CN100491528C (zh) | 2009-05-27 |
Family
ID=37582833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100283294A Active CN100491528C (zh) | 2006-06-29 | 2006-06-29 | 与利培酮临床疗效相关的核酸序列 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100491528C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109777870A (zh) * | 2018-11-07 | 2019-05-21 | 上海康黎医学检验所有限公司 | 一种用于指导人精神疾病用药的试剂盒及其检测方法 |
CN111440861A (zh) * | 2020-04-01 | 2020-07-24 | 上海市精神卫生中心(上海市心理咨询培训中心) | 甲基化的miR-124基因在制备用于诊断抑郁症的标志物中的用途 |
-
2006
- 2006-06-29 CN CNB2006100283294A patent/CN100491528C/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109777870A (zh) * | 2018-11-07 | 2019-05-21 | 上海康黎医学检验所有限公司 | 一种用于指导人精神疾病用药的试剂盒及其检测方法 |
CN109777870B (zh) * | 2018-11-07 | 2019-10-29 | 上海康黎医学检验所有限公司 | 一种用于指导人精神疾病用药的试剂盒及其检测方法 |
CN111440861A (zh) * | 2020-04-01 | 2020-07-24 | 上海市精神卫生中心(上海市心理咨询培训中心) | 甲基化的miR-124基因在制备用于诊断抑郁症的标志物中的用途 |
CN111440861B (zh) * | 2020-04-01 | 2022-11-04 | 上海市精神卫生中心(上海市心理咨询培训中心) | 甲基化的miR-124基因在制备用于诊断抑郁症的标志物中的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN100491528C (zh) | 2009-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stöck et al. | Ever-young sex chromosomes in European tree frogs | |
Xu et al. | Genome sequence and genetic diversity of the common carp, Cyprinus carpio | |
Knapp et al. | Phylogenetic relationships within Echinococcus and Taenia tapeworms (Cestoda: Taeniidae): an inference from nuclear protein-coding genes | |
Lee et al. | Neuronal genes for subcutaneous fat thickness in human and pig are identified by local genomic sequencing and combined SNP association study | |
Yang et al. | Identification of candidate growth-related SNPs and genes using GWAS in brown-marbled grouper (Epinephelus fuscoguttatus) | |
Che et al. | Characterization of the miiuy croaker (Miichthys miiuy) transcriptome and development of immune-relevant genes and molecular markers | |
Jiang et al. | De novo assembly and characterization of the transcriptome, and development of SSR markers in wax gourd (Benicasa hispida) | |
Abdullayev et al. | A reference transcriptome and inferred proteome for the salamander Notophthalmus viridescens | |
Wan et al. | Description of new mitochondrial genomes (Spodoptera litura, Noctuoidea and Cnaphalocrocis medinalis, Pyraloidea) and phylogenetic reconstruction of Lepidoptera with the comment on optimization schemes | |
Lloyd et al. | Next generation sequencing and comparative analyses of Xenopus mitogenomes | |
Rasal et al. | Status and future perspectives of single nucleotide polymorphisms (SNPs) markers in farmed fishes: Way ahead using next generation sequencing | |
Sun et al. | Expression analysis of microRNAs related to the skin ulceration syndrome of sea cucumber Apostichopus japonicus | |
Louro et al. | Characterization and refinement of growth related quantitative trait loci in European sea bass (Dicentrarchus labrax) using a comparative approach | |
CN109082464A (zh) | 一种检测高血压药物代谢相关基因的引物组和试剂盒 | |
Delroisse et al. | De novo transcriptome of the European brittle star Amphiura filiformis pluteus larvae | |
Saif-Ali et al. | KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects | |
van Geel et al. | A cascade of complex subtelomeric duplications during the evolution of the hominoid and Old World monkey genomes | |
CN101818195A (zh) | 猪miR-27a前体侧翼序列SNP作为猪产仔数性状的遗传标记及应用 | |
CN1884528A (zh) | 与利培酮临床疗效相关的核酸序列 | |
Yang et al. | Adaptive evolution of MRGX2, a human sensory neuron specific gene involved in nociception | |
Hu et al. | Genetic analysis of 15 mtDNA SNP loci in Chinese Yi ethnic group using SNaPshot minisequencing | |
CN101041854A (zh) | 一种原发性肝癌相关非编码小分子rna的多态性位点及其应用 | |
CN101033489A (zh) | 一种与原发性肝癌相关的cdc6基因的单核苷酸多态位点及其应用 | |
Sarropoulou et al. | Functional divergences of GAPDH isoforms during early development in two perciform fish species | |
WO2001092582A1 (en) | Haplotypes of the ube3a gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI GENOMEPILOT INSTITUTES OF GENOMICS AND HU Free format text: FORMER OWNER: SHANGHAI JIAO TONG UNIVERSITY Effective date: 20131218 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200240 MINHANG, SHANGHAI TO: 200136 PUDONG NEW AREA, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131218 Address after: 200136 Zaozhuang Road, Shanghai, room 667, No. 516, room Patentee after: Shanghai Baizhen genomics and human health research institute Address before: 200240 Dongchuan Road, Shanghai, No. 800, No. Patentee before: Shanghai Jiao Tong University |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 200136 Zaozhuang Road, Shanghai, room 667, No. 516, room Patentee after: SHANGHAI GENOMEPILOT INSTITUTES OF GENOMICS AND HUMAN HEALTH Address before: 200136 Zaozhuang Road, Shanghai, room 667, No. 516, room Patentee before: Shanghai Baizhen genomics and human health research institute |
|
TR01 | Transfer of patent right |
Effective date of registration: 20161208 Address after: 226133 Jiangsu city of Nantong Province Haimen Haimen District Linjiang Technology Park building A9 208 people Road Patentee after: HAIMEN PRECISIONGENES CO.,LTD. Address before: 200136 Zaozhuang Road, Shanghai, room 667, No. 516, room Patentee before: SHANGHAI GENOMEPILOT INSTITUTES OF GENOMICS AND HUMAN HEALTH |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 226100 building A9, biomedical technology pioneer park, Linjiang Town, Haimen District, Nantong City, Jiangsu Province Patentee after: Zhongke gene Biotechnology (Jiangsu) Co.,Ltd. Address before: 226133 No.208, Renmin West Road, A9 / F, Haimen Science Park, Linjiang New District, Haimen City, Nantong City, Jiangsu Province Patentee before: HAIMEN PRECISIONGENES Co.,Ltd. |